Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

By sjmartinez • April 15, 2024

Weld ED, McGowan I, Anton P, Fuchs EJ, Ho K, Carballo-Dieguez A, Rohan LC, Giguere R, Brand R, Edick S, Bakshi RP, Parsons T, Manohar M, Seigel A, Engstrom J, Elliott J, Jacobson C, Bagia C, Wang L, Al-Khouja A, Hartman DJ, Bumpus NN, Spiegel HML, Marzinke MA, Hendrix CW. Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01). J Infect Dis. 2024 Apr 12;229(4):1131-1140. doi: 10.1093/infdis/jiad535. PMID: 38019657; PMCID: PMC11011183.

Tags: Digestive Diseases, HIV, Microbicide, Pharmacodynamics, Pharmacokinetics, phase 1, preexposure prophylaxis, Publications

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across Racial and Ethnic Groups

Patel C, Abboud Y, Karkra R, Qureshi I, Gaglio P, Lingiah V, Al-Khazraji A, Hajifathalian K. Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across[...]

Reducing demographic bias in biomedical machine learning for cancer detection using cfDNA methylation

Li S, Zeng W, Li W, Liu CC, Zhou Y, Ni X, Stackpole ML, Yeh AH, Melehy A, Lu DS, Raman SS, Hsu W, Mishra[...]